Rivaroxaban

Overview

Rivaroxaban (BAY 59-7939) is a highly potent, selective and direct Factor Xa ( FXa ) inhibitor, achieving a strong gain in anti-FXa potency ( IC 50 0.7 nM; K i 0.4 nM).

Application

Products | Products > Disease Areas > Viral Infection | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Pancreatic Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Factor Xa

Product Information

• Catalog No.: HY-50903
• CAS No.: 366789-02-8
• Molecular Formula: C19H18ClN3O5S
• Molecular Weight: 435.88
• Purity: 99.93%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 1 year , -20°C, 6 months
• Solubility: 2.5 mg/mL (5.74 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source